August 2011 Slide of the Month
A systematic methodology was developed in order to create the process maps in such a way that different systems were comparable. To maximise comparability, the maps were limited to only the national level agencies that were directly involved in the assessment and reimbursement decision making of new pharmaceuticals.
The agencies (blue) involved in the system were identified. Connections were added to indicate where the sponsor (red) of the new medicine interacts with the agencies and where the agencies interact with each other. Independence from or inclusion within government was indicated by light blue shading.
Seven key functions were then mapped on the agencies to allow identification of where in the system such functions occur and how they interact. For the HTA function a task bar was developed in order to characterise a selection of defining elements of the process.
This slide appeared as part of a presentation by F Pichler at the 23rd Annual DIA EuroMeeting, Geneva (2011).
For detailed definitions and to download the slide, click the link below.
